EDESA BIOTECH, INC. (EDSA) Free cash flow 2016–2023
EDESA BIOTECH, INC. (EDSA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$6.6MFY2023 · since FY2016: -$4.9M → -$6.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -$6.6M | +46.0% |
| FY2022 | -$12.3M | +10.1% |
| FY2021 | -$13.7M | -173.9% |
| FY2020 | -$5.0M | — |
| FY2018 | -$1.3M | +74.1% |
| FY2017 | -$5.0M | -1.9% |
| FY2016 | -$4.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More EDSA financial trends
EDSA RevenueEDSA Net incomeEDSA Net marginEDSA Gross profitEDSA Gross marginEDSA Operating incomeEDSA Operating marginEDSA Operating cash flowEDSA Capital expendituresEDSA Return on equityEDSA Stock buybacksEDSA Dividends paidEDSA Total assetsEDSA Total liabilitiesEDSA Shareholders’ equityEDSA overview →